Masimo Corporation

MASINASDAQHealthcare● Active

$179.96

+$1.14(+0.63%)

Market Cap$9.4B

P/E Ratio—

52W High$179.96

52W Low$125.94

Avg Volume1.2M

Open$179.93

Beta1.10

Free Cash Flow Financials Revenue

Masimo Corporation (MASI) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

MASI · free cash flow · updated Jun 8, 2026

Core FCF metrics

MASI · FCF · TTM · margin & CAGR

Free cash flow was $197.8M for FY2026 (fiscal year ending 2026-01-03), up 36.1% year-over-year The FCF margin was 12.9%. Five-year CAGR stands at +8.6%.

FY2026 Free Cash Flow$197.8M▲ +36.1% YoY

Trailing 12M (TTM)$208.8Mtrailing 4 quarters sum

FCF Margin12.9%$197.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR+8.6%FY2021 → FY2026

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

MASI · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2026Latest$217.8M(19M)$197.8M▲ +36.1%12.9%

FY2024$196.4M(51M)$145.3M▲ +2170.3%6.9%

FY2023$94.1M(88M)$6.4M▲ +123.8%0.3%

FY2022$29.4M(56M)−$26.9M▼ 111.7%-1.3%

FY2021$264.6M(35M)$229.7M▲ +75.1%18.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

MASI · P/FCF · FCF yield · FCF per share

Masimo Corporation (MASI) trades at a FCF yield of 2.22% and a price-to-free-cash-flow ratio of 46.1x. FCF per share stands at $3.90, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

2.22%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$3.90

TTM FCF ÷ Shares Outstanding

Price / FCF

x46.1

Share Price ÷ FCF per Share

EV / FCF (TTM)

x46.9

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-01-03

Cash flow statement summary

MASI · cash flow statement · operating / investing / financing

For FY2026, Masimo Corporation generated $217.8M in operating cash flow and spent 19M in capital expenditures, yielding $197.8M in free cash flow.

Operating Activities

+$217.8M

Cash from core business operations

2026-01-03

Investing Activities

+$275.1M

CapEx, acquisitions & investments

2026-01-03

Financing Activities

−$520.7M

Buybacks, dividends & debt

2026-01-03

FCF FormulaOperating CF ($217.8M) − |CapEx| (19M) = FCF ($197.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

MASI vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Masimo CorporationYOU

MASI

$197.8M+36.1%13.0%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Masimo Corporation (MASI) reported free cash flow of $197.8M for FY2026 (fiscal year ending 2026-01-03), up 36.1% year-over-year. The FCF margin was 12.9%.

Based on available data, Masimo Corporation has maintained positive free cash flow for at least 14 fiscal year(s). FCF peaked at $392.5M in FY2016. The 5-year CAGR stands at +8.6%.

Masimo Corporation's FCF yield is 2.22% and price-to-FCF ratio is 46.1x for FY2026, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

MASI free cash flow · 8 questions

Masimo Corporation free cash flow was $197.8M for FY2026, up 36.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $208.8M.

MASI free cash flowMASI FCFMASI FCF 2026MASI free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Masimo Corporation · Masimo Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026